Evaluation of the Pharmaceutical Industry Investment Program

Productivity Commission

Microeconomics from University Library of Munich, Germany

Abstract: With the expiry of the Pharmaceutical Industry Investment Program (PIIP) in 2004, the Commission was asked to conduct an evaluation of the program’s rationale, effectiveness and efficiency. The study commenced in August 2002. The Commission found that this assistance scheme had significant deficiencies and should not be renewed in its current form when it expires.

Keywords: Clause (f); Drugs; Generic drugs; PBAC; PBPA; Pharmaceutical Benefits Advisory Committee; Pharmaceutical Benefits Pricing Authority’s; Pharmaceutical Benefits Scheme; Pharmaceutical Industry; Pharmaceutical Industry Investment Program; PIIP; R&D; Research and Deveoppment; Taxation (search for similar items in EconPapers)
JEL-codes: A (search for similar items in EconPapers)
Date: 2003-05-01
New Economics Papers: this item is included in nep-com and nep-hea
Note: Type of Document - PDF; prepared on IBM PC; to print on HP;
References: View complete reference list from CitEc
Citations: View citations in EconPapers (5)

Downloads: (external link)
https://econwpa.ub.uni-muenchen.de/econ-wp/mic/papers/0305/0305001.pdf (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:wpa:wuwpmi:0305001

Access Statistics for this paper

More papers in Microeconomics from University Library of Munich, Germany
Bibliographic data for series maintained by EconWPA ( this e-mail address is bad, please contact ).